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obtained by the new optimized plans confirm that the EIV 
method can guide optimization and improve plan quality. 
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Purpose or Objective: Pareto fronts are a powerful 
mathematical strategy to formalize the trade-off between a 
given set of mutually contradicting objectives. We use this 
strategy to determine the optimal block margin and 
prescription isodose for both optimal target coverage and 
normal tissue sparing for VMAT treatments in extracranial 
stereotactic radiotherapy. 
 
Material and Methods: Three spherical-shaped targets of 
different dimensions (20cc, 55cc and 101cc) were selected 
from our clinical database. GTV included macroscopic disease 
defined on CT. PTV was defined based on internal margin and 
setup margin. Healthy liver was considered whole liver minus 
GTV. A single fraction dose of 26 Gy was prescribed 
(PD=Prescription Dose). VMAT plans were generated with 
Ergo++ (Elekta) using a 10MV single arc. Pareto fronts based 
on (i) different MLC block margin around PTV (ranging from 
+4mm to -2mm with 1 mm step) and (ii) different 
prescription isodose line (IDS) ranging from 50% to 100% of PD 
were produced. For each block margin, the greatest IDS 
fulfilling the two criteria: 95% of PTV volume reached 100% of 
PD and 90% of PTV reached 99% of PD was considered as that 
providing the optimal clinical plan for target coverage. The 
liver mean dose, V7Gy and V12Gy were used together with 
the PTV coverage (1-V100) to generate the fronts. The ratio 
of the prescription isodose surface volume to PTV volume 
(conformity index CI), gradient index (GI=V50/V100), the 
ratio of normal tissue volume receiving 50% of prescription 
dose and PTV volume (NTV50/PTV), homogeneity index 
(HI=D2%/PD) and healthy liver irradiation in terms of mean 
dose, V7Gy and V12Gy were calculated to compare different 
plans 
 
Results: A total of about 450 plans (150 per lesion) were 
calculated for all block margins and isodose lines. Pareto 
fronts generated for one of the lesions are plotted in figure 
1a,b. For all block margins, PTV coverage is deteriorated 
with the decrease of liver Dmean, V7Gy and V12Gy. The front 
for 1mm MLC margin is situated below and on the left of the 
other fronts for all the three different target sizes. Figure 
1c,d show the GI plotted against the prescribed isodose lines 
and the HI index for the optimal clinical plans. In all cases GI 
shows a U-shaped behavior with minimum values at 1mm for 
all metrics. The location of these minimal points was found 
independent of tumor dimensions. Minimal GI values were 
found at HI values approximately equal to 1.3. Figure 1e and 
1c show the CI and the NTV50/PTV versus HI. With 1mm MLC 
margin the optimal prescription isodose line was found 77-
82% for the three different lesions. 
 
 
 
Conclusion: Pareto fronts provide a rigorous strategy to 
choice clinical optimal plans in SBRT treatments. Our 
evaluation shows that a 1mm MLC block margin provides the 
best results with regard healthy liver tissue irradiation and 
steepness of dose fallout. This choice provided optimal SBRT 
plans at dose prescription to 77%-82% isodose line for all 
target dimensions. 
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Purpose or Objective: Extremity soft tissue sarcomas (ESTS) 
are treated with combined surgery and radiotherapy, 
involving large volumes of healthy tissue. This increases late 
toxicity, which has a negative impact on quality of life. Due 
to the conformal dose distribution of protons a reduction of 
healthy tissue exposure can be expected. The clinical benefit 
in preventing long term toxicity can be fully exploited only if 
the reproducibility and stability of treatment delivery can be 
guaranteed. The aim of our study was to show the feasibility 
and robustness of actively scanned proton therapy with single 
and matched fields. 
 
Material and Methods: In 8 postoperative ESTS patients CTV 
was defined as GTV radially expanded by 1.5cm and 
longitudinally by 4cm. For PTV the CTV was expanded 
isotropically by 1cm [1]. The dose prescription was 60Gy 
(RBE) to D50% of the PTV (2Gy (RBE)/fraction). For treatment 
planning the software Raystation v4.7 (Raysearch 
Laboratories, Sweden) was used. 4/8 patients with PTVs 
longer than 18cm (maximal available field length) required 
field matching. Robust optimization is the method of choice 
in Raystation when two fields with different isocenters are 
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put together. The robustness was assessed by applying 
Hounsfield unit (HU) perturbations of 3.5% and isocenter 
shifts of 5mm. Single beam optimisation (SBO) using a 
horizontal beam line was used when possible. PTV constraints 
were D2% < 107%, D98% > 90% and V95% > 95% (ICRU). Limits 
to organs-at-risk (OAR) were the dose-surface area for the 
skin A60Gy (RBE) < 20cm2 [2], maximum dose to the bones 
DRBE, 2% < 60 Gy (RBE), maximum dose to the nerves and 
vessels DRBE, 2% < 70 Gy (RBE). 
[1] Haas et al 2012 IJROBP 84: 572-580 
[2] Sugahara et al 2012 RadiotherOncol 105: 226-231 
 
Results: Patients with field lengths < 18cm (PTV volumes: 
164-659 cm3) could be treated with SBO using 2 horizontal 
beams and table rotation. In the nominal plan, PTVV95% 
ranged from 96.3-98.9%. SkinA60Gy (RBE) was 10±7.5cm2. 
Treatment plans were robust against HU perturbations and 
5mm shifts in sup-inf and right-left direction with V95 never 
dropping below 93%. D2% and D98% of the PTV and OAR doses 
never exceeded the limits. Shifts of 5mm in ant-post 
direction caused severe underdosage in the PTV down to 
V95% of 68%. Robust optimisation in ant-post direction could 
increase these values up to 91%.  
For larger PTVs (420 cm3-2240cm3) field lengths ranged from 
25-34 cm. The length of the field overlapping region 
essentially influenced the robustness of the treatment plans. 
Isocenter shifts of 5mm to each other or apart resulted in a 
PTVD2% change of 7% for an overlap >6cm increasing up to 
15% for ≤ 6cm (Figure 1). 
 
 
Conclusion: Robust treatment plans could be achieved for 
ESTS patients employing a horizontal beam line only. Before 
clinical implementation, dosimetric monitoring of skin doses 
should be performed to verify the calculated values. If field 
matching is needed a maximal overlap of the matching fields 
should be guaranteed to avoid hot or cold spots in the 
overlapping area. 
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Purpose or Objective: During the last couple of years, 
volumetric modulated arc therapy (VMAT) is a treatment 
modality of increasing interest in radiation oncology. Thereby 
VMAT utilizes dynamic gantry rotation, dynamic MLC and 
varying dose rate. However, in addition the collimator angle 
could be changed dynamically, thus, increasing the degrees 
of freedom for the optimization, which might lead to 
improved dose distributions. This work investigates the 
feasibility of VMAT optimization including a dynamic 
collimator rotation. 
 
Material and Methods: In this work a 20 x 20 x 20 cm^3 
homogeneous water phantom with a cigar shaped target 
volume and a close-by spherical shaped critical structure was 
used. By means of the Eclipse Research Scripting a 
predefined collimator rotation was included to a partial arc 
in a not yet optimized treatment plan. For this purpose a 
different collimator angle was assigned for each dicom 
control point. Thereby the collimator rotation takes into 
account the physical limitations for the dose delivery. This 
treatment plan was then imported into the treatment 
planning system Eclipse using the Eclipse Research Scripting 
interface. Then the VMAT optimization was performed 
applying the PRO3 optimization algorithm in a research 
version of Eclipse. For the dose calculation of the optimized 
treatment plan the Swiss Monte Carlo Plan (SMCP) was used 
[1]. Similarly, a dose distribution was determined using a 
static collimator angle as typically applied in conventional 
VMAT applications. The resulting DVHs for the target and the 
critical structure were compared for the treatment plans. 
 
Results: The optimization of a VMAT treatment plan with a 
dynamically rotating collimator was successfully performed. 
The comparison of the DVHs for the target volume showed a 
slight improvement of the coverage as well as the dose 
homogeneity for the treatment plan using dynamic collimator 
rotation compared to the plan applying a fixed collimator 
angle. Additionally, the dose to the critical structure could 
be reduced when using the dynamic collimator rotation 
instead of a fixed collimator angle. 
 
Conclusion: The usage of a dynamic collimator rotation for 
VMAT is feasible and has the potential to improve the dose 
distribution for the target while reducing the dose to critical 
structures. This work was supported by Varian Medical 
Systems. 
References: 
[1] M.K. Fix, P. Manser, D. Frei, W. Volken, R. Mini, E.J. 
Born, An efficient framework for photon Monte Carlo 
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Purpose or Objective: Several studies suggest that IMRT can 
reduce toxicity in rectal cancer patients. A preconfigured 
plan model might improve daily clinical activity outcomes. 
Aim of this study was the evaluation of the performances of 
RapidPlan®Varian Medical System, a commercial model-
